Global Nicotinamide Riboside (NR) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Nicotinamide Riboside (NR) market size will reach 29.43 Million USD in 2025 and is projected to reach 53.08 Million USD by 2032, with a CAGR of 8.79% (2025-2032). Notably, the China Nicotinamide Riboside (NR) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Nicotinamide riboside (NR) is a form of vitamin B3, also known as niacin or nicotinic acid. It is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and regulation of gene expression. NR can be found naturally in trace amounts in some foods like milk, yeast, and certain vegetables, but it is also available as a dietary supplement. Research suggests that NR supplementation may support cellular health and function by boosting NAD+ levels, which decline with age and in certain health conditions. Some potential benefits of NR supplementation include improved mitochondrial function, enhanced metabolism, and protection against age-related decline. However, further studies are needed to fully understand the effects and potential therapeutic applications of NR supplementation.

The major global  manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, Tiantai Biotechnology, EnzymeWorks, Suzhou MyLand Pharm & Nutrition, Shenzhen Ejion Biotechnology, Zhejiang Jiahua, Weitai Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Nicotinamide Riboside (NR). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nicotinamide Riboside (NR) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Nicotinamide Riboside (NR) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nicotinamide Riboside (NR) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nicotinamide Riboside (NR) Include:

ChromaDex

Genex Formulas

Shandong Tianming Pharmaceutical

Bontac

Longer Livetech

Tiantai Biotechnology

EnzymeWorks

Suzhou MyLand Pharm & Nutrition

Shenzhen Ejion Biotechnology

Zhejiang Jiahua

Weitai Pharmaceutical

Nicotinamide Riboside (NR) Product Segment Include:

Purity ≤98%

Purity ＞98%

Nicotinamide Riboside (NR) Product Application Include:

Health Supplement

Pharmaceutical Additives

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Nicotinamide Riboside (NR) Capacity and Production Analysis

Chapter 3: Global Nicotinamide Riboside (NR) Industry PESTEL Analysis

Chapter 4: Global Nicotinamide Riboside (NR) Industry Porter's Five Forces Analysis

Chapter 5: Global Nicotinamide Riboside (NR) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global Nicotinamide Riboside (NR) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global Nicotinamide Riboside (NR) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, Nicotinamide Riboside (NR) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources